Use our pre-submission checklist
Avoid common mistakes on your manuscript.
1 Correction to: Drugs (2019) 79:1757–1775 https://doi.org/10.1007/s40265-019-01198-7
Page 5, Fig. 2 Key milestones in the development of budesonide.
Box that currently reads ‘First approval of budesonide nebuliser solution for use in asthma 1992’
Should read:
‘First approval of budesonide nebuliser suspension for use in asthma 1992’
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tashkin, D.P., Lipworth, B. & Brattsand, R. Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease. Drugs 79, 1911 (2019). https://doi.org/10.1007/s40265-019-01220-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-019-01220-y